… Reduction Act, explores how the Orphan Drug Act, passed in 1983 as … and equity challenges as the Orphan Drug Act intersects with modern drug … incentives for blockbuster drugs, refining orphan drug eligibility, and shifting toward more …

The FDA has granted orphan drug designation (ODD) to IFx-2. … tumor.2 Clinical Evidence and Orphan Drug Status The FDA’s decision … 1. TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 …

… (FDA) has granted orphan drug designation to the investigational … cancer. By receiving orphan drug designation, TuHURA Biosciences … release that receiving orphan drug designation highlights IFx … TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2 …

The FDA has granted orphan drug designation (ODD) to IFx-2. … paper. TuHURA Biosciences received FDA orphan drug designation for IFx-2.0 …

… Orphan Products Development has granted Orphan Drug Designation (ODD) to IFx-2 … in this patient population." Orphan drug designation provides seven years of …

… Regenerative Medical Product (Sakigake) and Orphan Drug designations for MCO-010 from … designations from the EMA and orphan drug and fast track designations for … FDA. Additionally, it has received orphan drug, fast track, and regenerative medicine …

The FDA has granted orphan drug designation (ODD) to zavabresnib (OPN- … broader clinical trial evaluation. “Receiving Orphan Drug Designation for zavabresib in myelofibrosis …

… Regenerative Medicine Advanced Therapy (RMAT), Orphan Drug, and Fast Track designations for … been granted Fast Track and Orphan Drug designations by the FDA. About …

… sale. RenovoCath with gemcitabine received Orphan Drug Designation for pancreatic cancer and …

… -resistant disease4. GIST qualifies for orphan drug designation in major regulatory jurisdictions …